If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

GRTX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 8.60%

Insider Buying (Last 12 Months): $212,350.00

Insider Selling (Last 12 Months): $0.00

Galera Therapeutics Insider Trading History Chart

Galera Therapeutics Share Price & Price History

^$2.56

▲ +0.12 (4.92%)

As of 03/31/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Galera Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/16/2023	Mark Bachleda	Insider	Buy	11,000	$2.25	$24,750.00	11,000
3/13/2023	Chris Degnan	CFO	Buy	10,000	$1.96	$19,600.00	10,000
3/10/2023	Mel Sorensen	CEO	Buy	100,000	$1.68	$168,000.00	332,044
12/17/2021	Linda West	Director	Buy	20,000	$2.74	$54,800.00
6/15/2021	Linda West	Director	Buy	10,000	$9.13	$91,300.00	40,000
6/2/2021	Linda West	Director	Buy	10,000	$8.65	$86,500.00	30,000
2/18/2021	Holdings A/S Novo	Major Shareholder	Sell	500,000	$10.58	$5,290,000.00	2,459,021
11/13/2020	Joel F Sussman	CAO	Sell	10,000	$10.32	$103,200.00	10,000
10/26/2020	Jon T Holmlund	Insider	Sell	2,244	$15.00	$33,660.00	2,244
10/15/2020	Holdings A/S Novo	Major Shareholder	Sell	450,000	$11.00	$4,950,000.00	2,959,021
10/5/2020	Jon T Holmlund	Insider	Sell	100	$12.00	$1,200.00	100
6/19/2020	Bioventures Ltd Novartis	Major Shareholder	Sell	1,001,312	$8.25	$8,260,824.00
6/17/2020	Bioventures Ltd Novartis	Major Shareholder	Sell	4,622	$9.27	$42,845.94
6/15/2020	Bioventures Ltd Novartis	Major Shareholder	Sell	6,164	$9.05	$55,784.20
6/12/2020	Bioventures Ltd Novartis	Major Shareholder	Sell	17,232	$8.72	$150,263.04
6/10/2020	Bioventures Ltd Novartis	Major Shareholder	Sell	8,532	$9.46	$80,712.72
6/8/2020	Bioventures Ltd Novartis	Major Shareholder	Sell	5,659	$9.66	$54,665.94
6/4/2020	Bioventures Ltd Novartis	Major Shareholder	Sell	4,088	$9.55	$39,040.40
6/2/2020	Bioventures Ltd Novartis	Major Shareholder	Sell	5,669	$9.68	$54,875.92
5/26/2020	Jon T Holmlund	Insider	Sell	692	$12.00	$8,304.00	692
5/11/2020	Jon T Holmlund	Insider	Sell	185	$12.00	$2,220.00	5,102
5/7/2020	Jon T Holmlund	Insider	Sell	2,059	$12.00	$24,708.00	3,064
5/5/2020	Jon T Holmlund	Insider	Sell	3,064	$12.16	$37,258.24	3,064

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Galera Therapeutics (NASDAQ:GRTX)

36.45% of Galera Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Galera Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/13/2023	Renaissance Technologies LLC	42,500	$63K	0.0%	-73.1%	0.149%
2/13/2023	Geode Capital Management LLC	174,924	$0.26M	0.0%	+5.6%	0.614%
2/10/2023	Sectoral Asset Management Inc.	1,666,666	$2.48M	0.5%	N/A	5.848%
11/15/2022	Two Sigma Advisers LP	14,100	$25K	0.0%	-72.3%	0.049%
11/15/2022	Two Sigma Investments LP	36,639	$64K	0.0%	-37.2%	0.129%
11/14/2022	Renaissance Technologies LLC	157,768	$0.28M	0.0%	-34.9%	0.554%
8/13/2022	Renaissance Technologies LLC	242,352	$0.32M	0.0%	-44.8%	0.904%
8/12/2022	Ensign Peak Advisors Inc	151,777	$0.20M	0.0%	+281.6%	0.566%
5/17/2022	Virtu Financial LLC	12,461	$30K	0.0%	N/A	0.047%
5/16/2022	Goldman Sachs Group Inc.	15,838	$38K	0.0%	-28.5%	0.059%
5/13/2022	Renaissance Technologies LLC	439,134	$1.05M	0.0%	N/A	1.639%
5/13/2022	Vanguard Group Inc.	437,383	$1.04M	0.0%	-6.7%	1.632%
5/12/2022	BlackRock Inc.	321,292	$0.77M	0.0%	+86.8%	1.199%
2/11/2022	Ensign Peak Advisors Inc	39,775	$0.15M	0.0%	N/A	0.150%
2/10/2022	Acadian Asset Management LLC	96,027	$0.44M	0.0%	N/A	0.363%
2/8/2022	Raymond James Financial Services Advisors Inc.	22,311	$0.10M	0.0%	-26.3%	0.084%
1/28/2022	Taylor Wealth Management Partners	11,635	$53K	0.0%	-79.9%	0.044%
1/25/2022	Belvedere Trading LLC	96,486	$0.26M	0.0%	N/A	0.365%
11/17/2021	Altium Capital Management LP	300,605	$2.44M	0.5%	+36.7%	1.137%
11/15/2021	Marshall Wace LLP	83,050	$0.67M	0.0%	-28.7%	0.315%
11/12/2021	AIGH Capital Management LLC	2,036,495	$16.50M	3.5%	+0.7%	7.724%
10/26/2021	Taylor Wealth Management Partners	58,012	$0.47M	0.2%	-11.0%	0.220%
9/22/2021	Nan Fung Group Holdings Ltd	613,223	$6.03M	1.9%	N/A	2.326%
8/25/2021	Marshall Wace LLP	116,508	$1.15M	0.0%	+115.3%	0.442%
8/17/2021	Worth Venture Partners LLC	469,174	$4.61M	1.7%	+119.0%	1.779%
8/17/2021	Millennium Management LLC	118,548	$1.17M	0.0%	N/A	0.450%
8/17/2021	Bridgeway Capital Management LLC	110,000	$1.08M	0.0%	+22.2%	0.417%
8/16/2021	State Street Corp	15,964	$0.16M	0.0%	-87.5%	0.061%
8/16/2021	Tibra Equities Europe Ltd	36,900	$0.36M	0.1%	N/A	0.140%
8/16/2021	Marshall Wace LLP	116,508	$1.15M	0.0%	+115.3%	0.442%
8/13/2021	Renaissance Technologies LLC	24,170	$0.24M	0.0%	-34.8%	0.092%
8/13/2021	Northern Trust Corp	14,795	$0.15M	0.0%	-84.4%	0.056%
8/13/2021	Altium Capital Management LP	219,900	$2.16M	0.5%	N/A	0.834%
8/13/2021	Jump Financial LLC	18,000	$0.18M	0.0%	N/A	0.071%
8/13/2021	Geode Capital Management LLC	71,256	$0.70M	0.0%	-38.7%	0.282%
8/13/2021	Vanguard Group Inc.	481,524	$4.73M	0.0%	-4.9%	1.907%
8/12/2021	AIGH Capital Management LLC	2,022,889	$19.89M	3.6%	+121.7%	8.010%
8/12/2021	Trexquant Investment LP	11,237	$0.11M	0.0%	N/A	0.044%
8/12/2021	JPMorgan Chase & Co.	35,973	$0.35M	0.0%	+52.1%	0.142%
8/12/2021	Ergoteles LLC	40,000	$0.39M	0.0%	N/A	0.158%
8/11/2021	BlackRock Inc.	185,141	$1.82M	0.0%	-68.7%	0.733%
8/11/2021	Deutsche Bank AG	275,935	$2.71M	0.0%	+4,367.1%	1.093%
8/5/2021	US Bancorp DE	10,579	$0.10M	0.0%	N/A	0.042%
6/10/2021	Perceptive Advisors LLC	254,664	$2.25M	0.0%	-21.6%	1.008%
5/19/2021	Worth Venture Partners LLC	214,242	$1.89M	0.9%	N/A	0.848%
5/17/2021	Schonfeld Strategic Advisors LLC	54,488	$0.48M	0.0%	N/A	0.216%
5/17/2021	Perceptive Advisors LLC	254,664	$2.25M	0.0%	-21.6%	1.008%
5/17/2021	Caas Capital Management LP	273,210	$2.41M	0.0%	+53.4%	1.082%
5/17/2021	Sphera Funds Management LTD.	323,348	$2.85M	0.2%	-30.9%	1.280%
5/17/2021	Novo Holdings A S	2,459,021	$21.69M	0.9%	-16.9%	9.737%
5/17/2021	Goldman Sachs Group Inc.	12,805	$0.11M	0.0%	-21.9%	0.051%
5/14/2021	Weiss Multi Strategy Advisers LLC	26,573	$0.23M	0.0%	-13.7%	0.105%
5/13/2021	Renaissance Technologies LLC	37,081	$0.33M	0.0%	+78.5%	0.147%
5/13/2021	Bank of New York Mellon Corp	32,303	$0.29M	0.0%	-5.7%	0.128%
5/12/2021	Northern Trust Corp	94,945	$0.84M	0.0%	-3.9%	0.376%
5/12/2021	Geode Capital Management LLC	116,266	$1.03M	0.0%	+2.2%	0.460%
5/12/2021	Panagora Asset Management Inc.	36,144	$0.32M	0.0%	+7.2%	0.143%
5/12/2021	UBS Group AG	4,349	$38K	0.0%	+122.3%	0.017%
5/7/2021	BlackRock Inc.	591,727	$5.22M	0.0%	+10.2%	2.343%
2/25/2021	Hsbc Holdings PLC	13,274	$0.14M	0.0%	N/A	0.053%
2/19/2021	JPMorgan Chase & Co.	22,564	$0.23M	0.0%	+262.1%	0.090%
2/16/2021	Squarepoint Ops LLC	12,428	$0.13M	0.0%	N/A	0.050%
2/12/2021	Caas Capital Management LP	178,141	$1.82M	0.0%	N/A	0.714%
2/11/2021	Northern Trust Corp	98,763	$1.01M	0.0%	-5.0%	0.396%
2/11/2021	Frazier Management LLC	241,000	$2.47M	0.2%	N/A	0.966%
2/10/2021	Renaissance Technologies LLC	20,770	$0.21M	0.0%	+58.9%	0.083%
2/10/2021	Panagora Asset Management Inc.	33,731	$0.35M	0.0%	+4,795.6%	0.135%
2/9/2021	Wells Fargo & Company MN	34,611	$0.35M	0.0%	+407.9%	0.139%
2/9/2021	Bank of New York Mellon Corp	34,273	$0.35M	0.0%	+42.0%	0.137%
2/8/2021	New York State Common Retirement Fund	8,800	$90K	0.0%	+1,000.0%	0.035%
2/5/2021	BlackRock Inc.	536,965	$5.49M	0.0%	+27.1%	2.152%
2/4/2021	State of Wisconsin Investment Board	12,300	$0.13M	0.0%	N/A	0.049%
2/2/2021	Taylor Wealth Management Partners	64,753	$0.66M	0.3%	+4.2%	0.260%
11/17/2020	VR Adviser LLC	51,653	$0.47M	0.1%	N/A	0.207%
11/13/2020	Morgan Stanley	2,777	$25K	0.0%	-52.1%	0.011%
11/10/2020	State Street Corp	82,772	$0.75M	0.0%	-3.1%	0.333%
11/6/2020	BlackRock Inc.	422,640	$3.82M	0.0%	+6.4%	1.699%
10/14/2020	Taylor Wealth Management Partners	62,171	$0.56M	0.3%	+3.7%	0.250%
8/25/2020	Nuveen Asset Management LLC	14,027	$100K	0.0%	N/A	0.056%
8/20/2020	Charles Schwab Investment Management Inc.	18,833	$0.14M	0.0%	N/A	0.076%
8/17/2020	Jacobs Levy Equity Management Inc.	36,161	$0.26M	0.0%	N/A	0.145%
8/14/2020	Bank of America Corp DE	9,737	$69K	0.0%	+206.0%	0.039%
8/13/2020	Tekla Capital Management LLC	1,041,845	$7.44M	0.3%	+150.0%	4.197%
8/12/2020	American International Group Inc.	5,348	$38K	0.0%	+427.9%	0.022%
8/12/2020	Bank of New York Mellon Corp	24,131	$0.17M	0.0%	+108.1%	0.097%
7/27/2020	Taylor Wealth Management Partners	59,930	$0.43M	0.2%	N/A	0.241%
7/20/2020	TCI Wealth Advisors Inc.	5,962	$43K	0.0%	N/A	0.024%
7/17/2020	Raymond James Financial Services Advisors Inc.	28,561	$0.20M	0.0%	N/A	0.115%
6/19/2020	State Street Corp	15,084	$0.14M	0.0%	N/A	0.061%
5/15/2020	RA Capital Management L.P.	893,115	$8.49M	0.3%	-15.3%	3.598%
5/15/2020	Squarepoint Ops LLC	12,670	$0.12M	0.0%	N/A	0.051%
5/15/2020	Weiss Multi Strategy Advisers LLC	48,492	$0.46M	0.0%	-19.2%	0.195%
5/15/2020	Morgan Stanley	4,747	$45K	0.0%	+101.5%	0.019%
5/14/2020	Wells Fargo & Company MN	5,285	$50K	0.0%	+3,757.7%	0.021%
5/14/2020	Geode Capital Management LLC	49,217	$0.47M	0.0%	+31.7%	0.198%
5/14/2020	Sphera Funds Management LTD.	475,677	$4.52M	0.6%	+0.9%	1.917%
5/11/2020	Ensign Peak Advisors Inc	8,925	$85K	0.0%	-64.3%	0.036%
5/11/2020	State Street Corp	15,084	$0.14M	0.0%	N/A	0.061%
5/6/2020	Bank of New York Mellon Corp	11,596	$0.11M	0.0%	N/A	0.047%
5/1/2020	BlackRock Inc.	71,557	$0.68M	0.0%	+5.8%	0.288%

Data available starting January 2016

Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical trial for the treatment of radiotherapy induced severe oral mucositis in patients with head and neck cancer (HNC); in Phase IIa clinical trial for the treatment of radiotherapy-induced esophagitis in patients with lung cancer; and in Phase IIa clinical trial for patients with HNC undergoing standard-of-care radiotherapy. It is also involved in developing GC4711, a superoxide dismutase mimetic product candidate, which is in Phase I/II clinical trial in combination with stereotactic body radiation therapy (SBRT) in patients with non-small cell lung cancer and locally advanced pancreatic cancer. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

Today's Range

Now: $2.56

$2.44

$2.61

50 Day Range

MA: $2.10

$1.59

$2.68

52 Week Range

Now: $2.56

$1.12

$2.84

Volume

545,020 shs

Average Volume

879,210 shs

Market Capitalization

$109.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.75

Who are the company insiders with the largest holdings of Galera Therapeutics?: Galera Therapeutics' top insider investors include:
Mel Sorensen (CEO)
Linda West (Director)
Mark Bachleda (Insider)
Chris Degnan (CFO)
Learn More about top insider investors at Galera Therapeutics.

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

GRTX Insider Trading

Galera Therapeutics Insider Trading History Chart

Galera Therapeutics Share Price & Price History

Galera Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Galera Therapeutics (NASDAQ:GRTX)

Institutional Buying and Selling by Quarter

Galera Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Galera Therapeutics?